BGM Group Ltd
BGM
Company Profile
Business description
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Contact
No. 152 Hongliang East 1st Street No. 1703
Tianfu New District
Chengdu610200
CHNT: +86 2864775180
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 September 2025
Employees
323
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,674.20 | 49.30 | -0.57% |
| CAC 40 | 7,589.66 | 36.21 | 0.48% |
| DAX 40 | 23,350.55 | 293.17 | 1.27% |
| Dow JONES (US) | 42,206.82 | 35.16 | 0.08% |
| FTSE 100 | 8,774.65 | 17.15 | -0.20% |
| HKSE | 23,516.76 | 13.72 | -0.06% |
| NASDAQ | 19,447.41 | 98.86 | -0.51% |
| Nikkei 225 | 38,252.46 | 150.77 | -0.39% |
| NZX 50 Index | 12,520.09 | 48.96 | -0.39% |
| S&P 500 | 5,967.84 | 13.03 | -0.22% |
| S&P/ASX 200 | 8,461.30 | 44.20 | -0.52% |
| SSE Composite Index | 3,365.07 | 5.17 | 0.15% |